Health-system pharmacy practice in 2050: Artificial intelligence—transforming the healthcare experience
American Journal of Health-System Pharmacy · 23.09.2025 · 82 (19) · e789-e790
DOI: 10.1093/ajhp/zxaf171 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 23.08.2025. Verfasst von Paul W Abramowitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: ASHP Bethesda, MD, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Editorial note: This is the first in a series of AJHP editorials that will be published in 2025 and 2026 with a goal of envisioning health-system pharmacy practice in 2050. This issue of AJHP contains the recently revised ASHP Statement on Artificial Intelligence in Pharmacy,1 which provides a vision for the role of the pharmacy workforce in contributing to the advancement of Artificial Intelligence (AI) in healthcare. This ASHP policy statement is an essential contribution to practice given the rapid rate of AI adoption we are witnessing today and the likelihood of its ubiquitous integration throughout the healthcare system by 2050. In his keynote remarks at the 2024 ASHP Pharmacy Futures meeting, futurist Mike Walsh emphasized that successful 21st-century organizations will leverage AI to transform experiences.2 The medication-use process and the pharmacy enterprise will not be exempted. The safe, effective, and appropriate use of medications in the current healthcare environment is dependent on highly automated processes that have been honed over the last 40 years. When they were introduced, these technologies were met with concern about their potential impact on roles and professional autonomy. The same is true now for AI. Some routine tasks will be eliminated. However, as with the technologies that preceded it, AI will ultimately expand rather than limit opportunities for pharmacists, pharmacy technicians, and the pharmacy enterprise. To this end, the authors of the ASHP Statement articulate the role of the pharmacy workforce in the selection and utilization, design, validation, implementation, ethical use, and ongoing evaluation of AI as it affects medications.
Autor:innen und Institutionen
- ASHP Bethesda, MD, USA.
Zitieren
APA
Abramowitz, P. W., & Cobaugh, D. J. (2025). Health-system pharmacy practice in 2050: Artificial intelligence—transforming the healthcare experience. American Journal of Health-System Pharmacy, 82(19), e789-e790. https://doi.org/10.1093/ajhp/zxaf171
Vancouver
Abramowitz PW, Cobaugh DJ. Health-system pharmacy practice in 2050: Artificial intelligence—transforming the healthcare experience. American Journal of Health-System Pharmacy. 2025;82(19):e789-e790. doi:10.1093/ajhp/zxaf171
BibTeX
@article{Abramowitz2025,
author = {Abramowitz, Paul W and Cobaugh, Daniel J},
title = {Health-system pharmacy practice in 2050: Artificial intelligence—transforming the healthcare experience},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
volume = {82},
number = {19},
pages = {e789--e790},
doi = {10.1093/ajhp/zxaf171}
}
EUVIMED